GE Healthcare Technologies Inc
GEHC82.611USD
-1.839-2.18%
Market hours （ET）Quotes delayed by 15 min
37.63BMarket Cap
17.02P/E TTM
More Details of GE Healthcare Technologies Inc Company
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
GE Healthcare Technologies Inc Info
Ticker SymbolGEHC
Company nameGE Healthcare Technologies Inc
IPO dateDec 15, 2022
CEOBankes (Jeannette)
Number of employees53000
Security typeOrdinary Share
Fiscal year-endDec 15
Address500 West Monroe Street
CityCHICAGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code60661
Phone18337351139
Websitehttps://www.gehealthcare.com
Ticker SymbolGEHC
IPO dateDec 15, 2022
CEOBankes (Jeannette)
Company Executives of GE Healthcare Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.81K
-4.01%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
64.93K
-1.69%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
41.00K
-2.13%
Ms. Jeannette Bankes
Ms. Jeannette Bankes
Chief Executive Officer - Patient Care Solutions
Chief Executive Officer - Patient Care Solutions
37.03K
--
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
+55.74%
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
+55.32%
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
13.61K
+55.32%
Dr. Risa J. Lavizzo-Mourey, M.D.
Dr. Risa J. Lavizzo-Mourey, M.D.
Lead Independent Director
Lead Independent Director
10.16K
+43.77%
Dr. Tomislav Mihaljevic, M.D.
Dr. Tomislav Mihaljevic, M.D.
Independent Director
Independent Director
9.12K
+51.33%
Mr. Kevin Michael O'Neill
Mr. Kevin Michael O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics
Chief Executive Officer - Pharmaceutical Diagnostics
165.00
-86.19%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.81K
-4.01%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
64.93K
-1.69%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
41.00K
-2.13%
Ms. Jeannette Bankes
Ms. Jeannette Bankes
Chief Executive Officer - Patient Care Solutions
Chief Executive Officer - Patient Care Solutions
37.03K
--
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
+55.74%
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
+55.32%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Total Imaging
2.20B
44.02%
Total Ultrasound
1.29B
25.74%
Total PCS
778.00M
15.54%
Total PDx
729.00M
14.56%
Other
6.00M
0.12%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Total Imaging
2.20B
44.02%
Total Ultrasound
1.29B
25.74%
Total PCS
778.00M
15.54%
Total PDx
729.00M
14.56%
Other
6.00M
0.12%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.37%
Dodge & Cox
6.04%
Capital Research Global Investors
5.48%
BlackRock Institutional Trust Company, N.A.
5.41%
State Street Investment Management (US)
4.31%
Other
67.38%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.37%
Dodge & Cox
6.04%
Capital Research Global Investors
5.48%
BlackRock Institutional Trust Company, N.A.
5.41%
State Street Investment Management (US)
4.31%
Other
67.38%
Shareholder Types
Shareholders
Proportion
Investment Advisor
47.07%
Investment Advisor/Hedge Fund
28.88%
Hedge Fund
3.52%
Research Firm
3.02%
Pension Fund
2.71%
Sovereign Wealth Fund
1.76%
Bank and Trust
1.29%
Insurance Company
0.80%
Individual Investor
0.28%
Other
10.65%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
2310
400.60M
85.71%
--
2025Q3
2366
400.81M
86.07%
+553.52K
2025Q2
2431
400.55M
88.05%
+24.13M
2025Q1
2426
405.65M
95.66%
-32.34M
2024Q4
2331
419.80M
91.27%
+20.88M
2024Q3
2167
398.38M
86.23%
+22.39M
2024Q2
2063
375.84M
84.85%
+4.36M
2024Q1
1976
370.75M
77.53%
+16.94M
2023Q4
1833
338.14M
75.18%
+5.23M
2023Q3
1683
332.60M
72.95%
+3.23M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
51.90M
11.37%
+696.51K
+1.36%
Jun 30, 2025
Dodge & Cox
23.57M
5.16%
+6.98M
+42.10%
Jun 30, 2025
Capital Research Global Investors
19.97M
4.38%
-1.99M
-9.05%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
24.63M
5.39%
-631.11K
-2.50%
Jun 30, 2025
State Street Investment Management (US)
19.66M
4.31%
+372.75K
+1.93%
Jun 30, 2025
Geode Capital Management, L.L.C.
11.94M
2.62%
+231.30K
+1.97%
Jun 30, 2025
Harris Associates L.P.
9.67M
2.12%
+4.04M
+71.68%
Jun 30, 2025
Invesco Capital Management (QQQ Trust)
9.37M
2.05%
-33.12K
-0.35%
Aug 31, 2025
Hotchkis and Wiley Capital Management, LLC
7.20M
1.58%
+1.45M
+25.17%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
6.32M
1.38%
+71.17K
+1.14%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco S&P Spin-Off ETF
7.25%
Global X HealthTech ETF
4.14%
iShares U.S. Medical Devices ETF
4.07%
Absolute Select Value ETF
2.89%
VanEck Morningstar Wide Moat ETF
2.36%
Knowledge Leaders Developed World ETF
2.22%
Invesco Zacks Mid-Cap ETF
1.91%
Simplify Health Care ETF
1.77%
State Street SPDR S&P Health Care Equipment ETF
1.76%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
1.75%
View more
Invesco S&P Spin-Off ETF
Proportion7.25%
Global X HealthTech ETF
Proportion4.14%
iShares U.S. Medical Devices ETF
Proportion4.07%
Absolute Select Value ETF
Proportion2.89%
VanEck Morningstar Wide Moat ETF
Proportion2.36%
Knowledge Leaders Developed World ETF
Proportion2.22%
Invesco Zacks Mid-Cap ETF
Proportion1.91%
Simplify Health Care ETF
Proportion1.77%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.76%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
Proportion1.75%
Dividend
A total of
96.00M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Sep 24, 2025
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on Nov 14, 2025 going ex on Oct 24, 2025
Oct 24, 2025
Nov 14, 2025
Oct 24, 2025
Jul 01, 2025
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on Aug 15, 2025 going ex on Jul 25, 2025
Jul 25, 2025
Aug 15, 2025
Jul 25, 2025
Mar 27, 2025
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on May 15, 2025 going ex on Apr 25, 2025
Apr 25, 2025
May 15, 2025
Apr 25, 2025
Nov 21, 2024
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 14, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Feb 14, 2025
Jan 14, 2025
Sep 18, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 15, 2024
Oct 18, 2024
Jun 26, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 15, 2024
Jul 19, 2024
Mar 22, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on May 15, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 15, 2024
Apr 18, 2024
Dec 08, 2023
GEHC.NB Final Cash Dividend of gross USD 0.03 paid on Feb 15, 2024 going ex on Jan 12, 2024
Jan 16, 2024
Feb 15, 2024
Jan 12, 2024
Sep 22, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 15, 2023
Oct 19, 2023
Jun 23, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 15, 2023
Jul 20, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of GE Healthcare Technologies Inc?
The top five shareholders of GE Healthcare Technologies Inc are:
The Vanguard Group, Inc. holds 51.90M shares, accounting for 11.37% of the total shares.
Dodge & Cox holds 23.57M shares, accounting for 5.16% of the total shares.
Capital Research Global Investors holds 19.97M shares, accounting for 4.38% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 24.63M shares, accounting for 5.39% of the total shares.
State Street Investment Management (US) holds 19.66M shares, accounting for 4.31% of the total shares.
The Vanguard Group, Inc. holds 51.90M shares, accounting for 11.37% of the total shares.
Dodge & Cox holds 23.57M shares, accounting for 5.16% of the total shares.
Capital Research Global Investors holds 19.97M shares, accounting for 4.38% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 24.63M shares, accounting for 5.39% of the total shares.
State Street Investment Management (US) holds 19.66M shares, accounting for 4.31% of the total shares.
What are the top three shareholder types of GE Healthcare Technologies Inc?
The top three shareholder types of GE Healthcare Technologies Inc are:
The Vanguard Group, Inc.
Dodge & Cox
Capital Research Global Investors
The Vanguard Group, Inc.
Dodge & Cox
Capital Research Global Investors
How many institutions hold shares of GE Healthcare Technologies Inc (GEHC)?
As of 2025Q4, 2310 institutions hold shares of GE Healthcare Technologies Inc, with a combined market value of approximately 400.60M, accounting for 85.71% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.36%.
What is the biggest source of revenue for GE Healthcare Technologies Inc?
In FY2025Q2, the Total Imaging business generated the highest revenue for GE Healthcare Technologies Inc, amounting to 2.20B and accounting for 44.02% of total revenue.
